市场调查报告书
商品编码
1533632
医疗旅游市场规模、份额和成长分析:按治疗类型、按服务供应商、按目的地、按地区 - 产业预测,2024-2031 年Medical Tourism Market Size, Share, Growth Analysis, By Treatment Type (Cardiovascular, Orthopedic), By Service Provider (Private, Public), By Destination (Domestic, International), By Region - Industry Forecast 2024-2031 |
2022年医疗旅游市场规模将达到173.5亿美元,预测期内(2024-2031年)复合年增长率为19.2%,从2023年的207亿美元增至2031年的842.9亿美元,预计将增长至2022亿美元增至2031年的842.9亿美元,预计将增长至2022亿美元增至2031年的842.9亿美元,预计将增长至2022亿美元年的173.5亿美元。
预计未来几年医疗旅游业将大幅成长。有几个因素促成了这种增长,包括技术和治疗的进步、流动性的增加、负担能力以及不断变化的医疗保健需求。该市场的主要驱动因素是患者所在国家的医疗保健服务高成本。此外,保险未承保的选择性治疗,例如变性手术、不孕症治疗、植入和拉皮,也推动了医疗旅游的需求。已开发国家的优质照护与泰国和马来西亚等新兴国家的照护之间的成本差异很大。由于资源更便宜且营运成本更低,这些开发中国家的成本显着降低。例如,冠状动脉成形术在美国的费用为 55,000 美元至 57,000 美元,而在马来西亚的费用为 4,500 美元至 10,000 美元。新加坡、马来西亚、印度和泰国等治疗地点吸引了来自美国和欧洲的患者,并且提供的治疗费用比本国低 55% 至 70%。新兴国家也拥有技术精湛的外科医生,他们每年为数千名患者进行各种手术。马来西亚的医疗费用比美国、英国和其他欧洲已开发国家低约30%至40%。这种负担能力延伸到各种各样的手术,包括拉皮、脸部修饰、牙贴面、隆乳、植入和抽脂。由于先进的医疗保健系统和低价的高品质服务,该市场预计将增长。然而,延误必要的治疗是有害的。例如,延迟髋关节置换术可能会导致病情进一步恶化、活动能力下降、疼痛加剧以及失去髋关节表面置换置换术等微创手术选择。
Medical tourism market size was valued at USD 17.35 billion in 2022 and is poised to grow from USD 20.7 billion in 2023 to USD 84.29 billion by 2031, growing at a CAGR of 19.2% during the forecast period (2024-2031).
Medical tourism is anticipated to grow significantly in the coming years. Several factors contribute to this growth, including advancements in technology and treatments, increased mobility, affordability, and evolving healthcare needs. A major driver for this market is the high cost of healthcare services in patients' home countries. Additionally, the availability of elective procedures such as sex change surgeries, infertility treatments, dental implants, and facelifts-often not covered by insurance-has boosted the demand for medical tourism. The cost difference between high-quality treatments in developed countries and those in developing countries like Thailand and Malaysia is notable. In these developing nations, the costs are significantly lower, thanks to more affordable resources and lower operational expenses. For example, coronary angioplasty, which costs between USD 55,000 and USD 57,000 in the U.S., ranges from USD 4,500 to USD 10,000 in Malaysia. Destinations such as Singapore, Malaysia, India, and Thailand attract patients from the U.S. and Europe, offering treatments at 55% to 70% lower costs compared to their home countries. Emerging countries also have skilled surgeons who perform a variety of procedures for numerous patients annually. In Malaysia, medical expenses are approximately 30% to 40% lower than in the U.S., U.K., and other developed European countries. This affordability extends to various surgeries, including facelifts, facial remodeling, dental veneers, breast augmentation, implants, and liposuction. The market is expected to grow due to the availability of advanced healthcare systems and high-quality services at lower prices. However, delays in necessary treatments can be detrimental; for instance, postponing hip replacement surgery could lead to further deterioration, reduced mobility, increased pain, and the loss of options for less invasive procedures like hip resurfacing.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Tourism market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Medical Tourism Market Segmental Analysis
The global medical tourism market is segmented on the basis of treatment type, service provider, destination, and region. Based on treatment type, the market is segmented into cardiovascular treatment, orthopedic treatment, cosmetic treatment, bariatric treatment, dental treatment, ophthalmology treatment, infertility treatment, alternative medicine, and other services. Based on service provider, the market is segmented into public and private. Based on destination, the market is segmented into domestic and international. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Medical Tourism Market
The expansion of the medical tourism market is driven by government initiatives and increased investments in developing advanced healthcare infrastructure. Supportive government policies, such as those promoting micro-holidays and investments in improving air connectivity and other transportation options, are contributing to market growth. Additionally, government efforts that facilitate medical tourism are playing a significant role in this expansion. Access to information about available treatments, their costs, and the top medical centers also raises awareness and encourages medical tourism. Moreover, the shortage of specialized healthcare professionals is prompting patients to seek specialized surgeries abroad, further driving the growth of medical tourism.
Restraints in the Global Medical Tourism Market
The growth of medical tourism relies heavily on patients' ability to travel to other countries for treatments. However, the COVID-19 pandemic significantly disrupted this dynamic, with governments worldwide imposing travel restrictions that adversely impacted the market. International tourist arrivals dropped by approximately 72% globally in 2020 due to the pandemic. These restrictions led to a sharp decline in medical procedures for international patients, with destinations, particularly in the Asia-Pacific region, experiencing an 84% reduction in 2020. Consequently, the medical tourism market's value decreased due to COVID-19, and its recovery to pre-pandemic levels is expected to take time.
Market Trends of the Global Medical Tourism Market
The global medical tourism market is experiencing significant growth due to several factors. According to the Medical Tourism Association, approximately 14 million people travel abroad each year for various treatments, including routine check-ups. This trend is particularly notable in destinations like Dubai, Singapore, and Thailand, where treatment costs are generally lower compared to some developed countries. Singapore, for instance, attracts around 500,000 patients annually, with Indonesia contributing half of this number. The growing demand for procedures such as beauty enhancements and other treatments continues to drive this trend. Another key factor fueling the growth of medical tourism is the substantial cost savings offered by healthcare services in Asian countries compared to private facilities in the U.S. For example, heart surgery in Thailand costs about $13,000, whereas the same procedure can reach up to $113,000 in the U.S., according to Apollo Hospitals. Similarly, hip replacement surgeries in Thailand are priced around $7,800, while in the U.S., the cost can be $50,000. Moreover, advancements in technology across various countries further boost market growth. The increasing demand for cosmetic surgeries, with costs in the U.S. ranging from $4,500 to $12,500, also contributes to this trend. Many individuals choose to travel abroad for high-quality services at more affordable prices, making medical tourism an appealing option.